KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $73,000 | -81.7% | 21,459 | -79.8% | 0.00% | -75.0% |
| Q2 2018 | $399,000 | +229.8% | 106,091 | +364.9% | 0.00% | +300.0% |
| Q3 2016 | $121,000 | -48.5% | 22,822 | -54.6% | 0.00% | -50.0% |
| Q1 2016 | $235,000 | +217.6% | 50,255 | +139.9% | 0.00% | – |
| Q3 2015 | $74,000 | -45.6% | 20,948 | +118.0% | 0.00% | -100.0% |
| Q4 2014 | $136,000 | -82.7% | 9,610 | -79.1% | 0.00% | -66.7% |
| Q1 2014 | $784,000 | +553.3% | 46,019 | +396.6% | 0.00% | – |
| Q4 2013 | $120,000 | -33.3% | 9,267 | -48.0% | 0.00% | -100.0% |
| Q3 2013 | $180,000 | – | 17,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |